© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
May 07, 2021
More than half of participants in the MDMA-assisted therapy arm no longer qualified for a post-traumatic stress disorder diagnosis after 3 sessions, compared to 32% in the control arm.
April 29, 2021
Although therapeutics and vaccines for COVID-19 have dominated the news in the last year, development of other drugs has continued.
Although transthyretin can play a negative role in patients with amyloidosis, it may have protective effects in patients with Alzheimer disease.
April 28, 2021
Women who had migraines before menopause had a 29% increased risk of developing high blood pressure after menopause.
April 22, 2021
People who used positive airway pressure therapy were less likely than others to receive a new diagnosis of dementia or mild cognitive impairment over the next 3 years.
April 14, 2021
Research is the first to link chronic sinus inflammation with a neurobiological change.
April 12, 2021
A new study published in Nature Communications used artificial intelligence (AI) to identify 3 new multiple sclerosis (MS) subtypes, which may help identify which individuals are more likely to have disease progression, according to the authors.
April 01, 2021
April is Parkinson’s Awareness Month, so what better time to refresh your understanding and promote awareness around Parkinson disease than now?
March 19, 2021
Nine in 10 patients with multiple sclerosis who received the medication did not have worsening of 3-month disability, and ponesimod showed a numerical benefit in delaying disability progression.
March 18, 2021
Additionally, the study revealed for the first time the physiological reason for the neutral protection is increased blood flow to the brain as a result of higher levels of progesterone.